Rana McKay, Professor of Medicine and Urology at UC San Diego Health, Co-Leader of the GU Oncology Program at Moores Cancer Center, shared a post on X:
”Excellent presentation by Paul Nguyen on EnzaRad. Heterogenous population but N1/Stampede high risk group appears to benefit.”
You can also read.
ESMO 2025 Day 1 Highlights Not to Miss
ESMO 2025 Day 2 Highlights Not to Miss
